Clinical Trial Recruitment

One of the largest oncology trial networks in the nation

The TIME Network powers smart sites, creating a network poised to accelerate clinical development

Sites can open upfront or after they have identified a patient in our Just-In-Time model which enables activation just a few days before the study opens at your site.

Our vast TIME network of academic medical centers and community-based practices continues to grow, enabling trial access for all patients—regardless of location.

Activate sites quickly, before or after patient identification

The TIME network complements your traditional trial sites by bringing your study to patients faster, in locations where they already receive care. We do this through rapid site activation, standardized study start-up documentation, and site engagement initiatives.

Expedited Activation

Through a series of streamlined activities and agreements, sites may be activated in ~30 business days prior to identifying the first eligible patient for your trial

Just-in-Time Activation

Utilizing the same operational efficiencies, TIME can help you activate new sites for your trial in ~10 business days for an identified eligible patient.

Support for your US-based trial enrollment plan
85% of patients with cancer are treated in community centers ¹. Tempus’ TIME Network includes hundreds of community site locations across the U.S., supporting efforts to enroll US-based patients and diversity plans due to the representative patient population.

TIME also supports your ability to deploy a trial within days at any location within the community via Just-In-Time.

1. National Cancer Institute. (2017, September 21). Bringing Research to the Community to Reduce Cancer Disparities. https://www.cancer.gov/research/areas/disparities/chanita-hughes-halbert-clinical-trials-community-access
2. TIME county ethnicity is calculated using weighted average of county population using the ethnicity breakdown of each county of active TIME sites,10/2024. Census data from www.data.census.gov Accessed 10/2024

Next Trials offers AI-enabled technology and services designed to support clinical researchers along the clinical trials spectrum, focusing on trial portfolio management, prescreening, and metrics.

Our AI-driven platform streamlines clinical trials by helping our customers automate patient pre-screening through multimodal data, optimizing enrollment workflows for clinicians, and providing self-service tools for cohort building and feasibility research.*

*Feature coming soon